Jump Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Jump Financial’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.81M	Buy	+402,846	New	+$8.38M	0.07%	314
2026 Q1	–	Sell	-163,915	Closed	-$3.44M	–	2359
2025 Q4	$3.44M	Buy	163,915 +31,214	+24%	+$545K	0.04%	484
2025 Q3	$2.04M	Sell	132,701 -248,334	-65%	-$3.25M	0.02%	728
2025 Q2	$3.57M	Buy	+381,035	New	+$4.19M	0.04%	526
2025 Q1	–	Sell	-173,890	Closed	-$2.3M	–	1990
2024 Q4	$2.3M	Buy	173,890 +77,699	+81%	+$1.33M	0.05%	465
2024 Q3	$1.85M	Buy	96,191 +58,691	+157%	+$1.21M	0.04%	550
2024 Q2	$770K	Buy	+37,500	New	+$785K	0.02%	942
2023 Q4	–	Sell	-154,786	Closed	-$2.25M	–	2210
2023 Q3	$2.25M	Buy	154,786 +118,500	+327%	+$2.24M	0.08%	324
2023 Q2	$759K	Buy	+36,286	New	+$755K	0.03%	825
2022 Q2	–	Sell	-41,800	Closed	-$726K	–	1994
2022 Q1	$726K	Sell	41,800 -13,813	-25%	-$233K	0.03%	655
2021 Q4	$1.22M	Buy	+55,613	New	+$1.03M	0.08%	332
2021 Q1	–	Sell	-16,011	Closed	-$356K	–	1256
2020 Q4	$356K	Buy	+16,011	New	+$332K	0.06%	527

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Jump Financial's SNDX Position: Q2 2026 in Review

Jump Financial opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 402,846 shares worth $8.81M. The stake represents 0.07% of the portfolio and ranks #314 among its holdings. This is a return to the name: Jump Financial previously reported a position in SNDX as recently as Q4 2025.

Jump Financial first reported a position in SNDX in Q4 2020 and has held it in 12 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Jump Financial held 402,846 shares of Syndax Pharmaceuticals worth $8.81M as of Q2 2026.
Syndax Pharmaceuticals was a new Jump Financial position in Q2 2026.
Syndax Pharmaceuticals made up 0.07% of Jump Financial's portfolio in Q2 2026, its #314 holding.
Jump Financial first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.